SynthesisCardiovascular drugs and therapy2022

Five Years of Sacubitril/Valsartan-a Safety Analysis of Randomized Clinical Trials and Real-World Pharmacovigilance.

Yee Soo Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.